Cargando…

Distribution and Clonality of drug-resistant tuberculosis in South Africa

BACKGROUND: Studies have shown that drug-resistant tuberculosis (DR-TB) in South Africa (SA) is clonal and is caused mostly by transmission. Identifying transmission chains is important in controlling DR-TB. This study reports on the sentinel molecular surveillance data of Rifampicin-Resistant (RR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Halima, Ratabane, John, Erasmus, Linda, Gardee, Yasmin, Omar, Shaheed, Dreyer, Andries, Ismail, Farzana, Bhyat, Zaheda, Lebaka, Tiisetso, van der Meulen, Minty, Gwala, Thabisile, Adelekan, Adeboye, Diallo, Karidia, Ismail, Nazir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161895/
https://www.ncbi.nlm.nih.gov/pubmed/34044775
http://dx.doi.org/10.1186/s12866-021-02232-z
_version_ 1783700601759072256
author Said, Halima
Ratabane, John
Erasmus, Linda
Gardee, Yasmin
Omar, Shaheed
Dreyer, Andries
Ismail, Farzana
Bhyat, Zaheda
Lebaka, Tiisetso
van der Meulen, Minty
Gwala, Thabisile
Adelekan, Adeboye
Diallo, Karidia
Ismail, Nazir
author_facet Said, Halima
Ratabane, John
Erasmus, Linda
Gardee, Yasmin
Omar, Shaheed
Dreyer, Andries
Ismail, Farzana
Bhyat, Zaheda
Lebaka, Tiisetso
van der Meulen, Minty
Gwala, Thabisile
Adelekan, Adeboye
Diallo, Karidia
Ismail, Nazir
author_sort Said, Halima
collection PubMed
description BACKGROUND: Studies have shown that drug-resistant tuberculosis (DR-TB) in South Africa (SA) is clonal and is caused mostly by transmission. Identifying transmission chains is important in controlling DR-TB. This study reports on the sentinel molecular surveillance data of Rifampicin-Resistant (RR) TB in SA, aiming to describe the RR-TB strain population and the estimated transmission of RR-TB cases. METHOD: RR-TB isolates collected between 2014 and 2018 from eight provinces were genotyped using combination of spoligotyping and 24-loci mycobacterial interspersed repetitive-units-variable-number tandem repeats (MIRU-VNTR) typing. RESULTS: Of the 3007 isolates genotyped, 301 clusters were identified. Cluster size ranged between 2 and 270 cases. Most of the clusters (247/301; 82.0%) were small in size (< 5 cases), 12.0% (37/301) were medium sized (5–10 cases), 3.3% (10/301) were large (11–25 cases) and 2.3% (7/301) were very large with 26–270 cases. The Beijing genotype was responsible for majority of RR-TB cases in Western and Eastern Cape, while the East-African-Indian-Somalian (EAI1_SOM) genotype accounted for a third of RR-TB cases in Mpumalanga. The overall proportion of RR-TB cases estimated to be due to transmission was 42%, with the highest transmission-rate in Western Cape (64%) and the lowest in Northern Cape (9%). CONCLUSION: Large clusters contribute to the burden of RR-TB in specific geographic areas such as Western Cape, Eastern Cape and Mpumalanga, highlighting the need for community-wide interventions. Most of the clusters identified in the study were small, suggesting close contact transmission events, emphasizing the importance of contact investigations and infection control as the primary interventions in SA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-021-02232-z.
format Online
Article
Text
id pubmed-8161895
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81618952021-06-01 Distribution and Clonality of drug-resistant tuberculosis in South Africa Said, Halima Ratabane, John Erasmus, Linda Gardee, Yasmin Omar, Shaheed Dreyer, Andries Ismail, Farzana Bhyat, Zaheda Lebaka, Tiisetso van der Meulen, Minty Gwala, Thabisile Adelekan, Adeboye Diallo, Karidia Ismail, Nazir BMC Microbiol Research BACKGROUND: Studies have shown that drug-resistant tuberculosis (DR-TB) in South Africa (SA) is clonal and is caused mostly by transmission. Identifying transmission chains is important in controlling DR-TB. This study reports on the sentinel molecular surveillance data of Rifampicin-Resistant (RR) TB in SA, aiming to describe the RR-TB strain population and the estimated transmission of RR-TB cases. METHOD: RR-TB isolates collected between 2014 and 2018 from eight provinces were genotyped using combination of spoligotyping and 24-loci mycobacterial interspersed repetitive-units-variable-number tandem repeats (MIRU-VNTR) typing. RESULTS: Of the 3007 isolates genotyped, 301 clusters were identified. Cluster size ranged between 2 and 270 cases. Most of the clusters (247/301; 82.0%) were small in size (< 5 cases), 12.0% (37/301) were medium sized (5–10 cases), 3.3% (10/301) were large (11–25 cases) and 2.3% (7/301) were very large with 26–270 cases. The Beijing genotype was responsible for majority of RR-TB cases in Western and Eastern Cape, while the East-African-Indian-Somalian (EAI1_SOM) genotype accounted for a third of RR-TB cases in Mpumalanga. The overall proportion of RR-TB cases estimated to be due to transmission was 42%, with the highest transmission-rate in Western Cape (64%) and the lowest in Northern Cape (9%). CONCLUSION: Large clusters contribute to the burden of RR-TB in specific geographic areas such as Western Cape, Eastern Cape and Mpumalanga, highlighting the need for community-wide interventions. Most of the clusters identified in the study were small, suggesting close contact transmission events, emphasizing the importance of contact investigations and infection control as the primary interventions in SA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-021-02232-z. BioMed Central 2021-05-28 /pmc/articles/PMC8161895/ /pubmed/34044775 http://dx.doi.org/10.1186/s12866-021-02232-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Said, Halima
Ratabane, John
Erasmus, Linda
Gardee, Yasmin
Omar, Shaheed
Dreyer, Andries
Ismail, Farzana
Bhyat, Zaheda
Lebaka, Tiisetso
van der Meulen, Minty
Gwala, Thabisile
Adelekan, Adeboye
Diallo, Karidia
Ismail, Nazir
Distribution and Clonality of drug-resistant tuberculosis in South Africa
title Distribution and Clonality of drug-resistant tuberculosis in South Africa
title_full Distribution and Clonality of drug-resistant tuberculosis in South Africa
title_fullStr Distribution and Clonality of drug-resistant tuberculosis in South Africa
title_full_unstemmed Distribution and Clonality of drug-resistant tuberculosis in South Africa
title_short Distribution and Clonality of drug-resistant tuberculosis in South Africa
title_sort distribution and clonality of drug-resistant tuberculosis in south africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161895/
https://www.ncbi.nlm.nih.gov/pubmed/34044775
http://dx.doi.org/10.1186/s12866-021-02232-z
work_keys_str_mv AT saidhalima distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT ratabanejohn distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT erasmuslinda distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT gardeeyasmin distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT omarshaheed distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT dreyerandries distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT ismailfarzana distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT bhyatzaheda distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT lebakatiisetso distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT vandermeulenminty distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT gwalathabisile distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT adelekanadeboye distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT diallokaridia distributionandclonalityofdrugresistanttuberculosisinsouthafrica
AT ismailnazir distributionandclonalityofdrugresistanttuberculosisinsouthafrica